Ostatní
Návod 
Fate Therapeutics, Inc.
FATE
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.1B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-67%
ROA
-45%
PE
-1
PS
20
Cena 1R
1-2
⌀ Cena
1.14
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
04-03-2026
Poslední dividenda
Profil
Fate Therapeutics, Inc., biofarmaceutická společnost v klinickém stadiu, vyvíjí naprogramované buněčné imunoterapie pro léčbu rakoviny a imunitních poruch po celém světě. Jeho imunoonkologické programy pro NK a T buňky jsou ve vývoji a zahrnují FT516 pro léčbu akutní myeloidní leukémie (AML) B-buněčného lymfomu a pokročilého solidního tumoru; FT596 pro léčbu B-buněčného lymfomu a chronické lymfocytární leukémie; FT538 pro léčbu AML a mnohočetného myelomu; FT576 pro léčbu mnohočetného myelomu; FT819 pro léčbu hematologických malignit a solidních tumorů; FT536 pro léčbu solidních tumorů; a FT500 pro léčbu pokročilých solidních tumorů. Společnost má dohodu o spolupráci a opci s Ono Pharmaceutical Co. Ltd. pro vývoj a komercializaci dvou off-the-shelf iPSC-odvozených CAR T-cell produktů kandidátů; strategickou výzkumnou spolupráci a licenční smlouvu s Juno Therapeutics, Inc. pro testování a identifikaci malých molekulových modulátorů, které zvyšují terapeutické vlastnosti geneticky-inženýrských T-buněčných imunoterapií; a dohodu o spolupráci a opci s Janssen Biotech, Inc. Fate Therapeutics, Inc. byla založena v roce 2007 a sídlí v San Diegu, Kalifornie.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
181
Založení
2013-10-01
Podobné společnosti
$ 1.34
+ $ 0.06
$ 18.94
+ $ 0.24
$ 2.96
- $ 0.01
$ 1.23
+ $ 0.04
$ 2.12
+ $ 0.01
$ 4.44
- $ 0.19
$ 4.24
- $ 0.50
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 6.6 | 6.6 | 13.6 | 63.5 | 96.3 | 55.8 | 31.4 | 10.7 | 4.7 | 4.1 | 4.4 | 2.4 | 0.0 | 1.0 | 2.7 | 1.2 | |
| Cost of Revenues | 3.1 | 12.9 | 0.0 | 161.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | -6.3 | -6.3 | 13.6 | -98.2 | 96.3 | 55.8 | 31.4 | 10.7 | 4.7 | 4.1 | 4.4 | 2.4 | 0.0 | 1.0 | 2.7 | 1.2 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 1.4 | 1.7 | 1.9 | 1.6 | 1.9 | 3.1 | 6.8 | 1.9 | 1.7 | 1.9 | |
| Cost of Revenues | 3.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.7 | 4.8 | 4.9 | 4.7 | |
| Gross Profit | -11.5 | 1.7 | 1.9 | 1.6 | 1.9 | 3.1 | 2.1 | -2.9 | -3.2 | -2.8 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 172.6 | 320.5 | 215.5 | 125.6 | 87.8 | 56.0 | 34.4 | 26.5 | 19.9 | 16.4 | 12.0 | 12.0 | 9.9 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 79.4 | 84.2 | 57.3 | 33.9 | 23.6 | 15.8 | 11.9 | 9.9 | 10.4 | 8.5 | 6.6 | 4.2 | 4.6 | |
| Depreciation & Amortization | 0.0 | 9.3 | 19.0 | 18.3 | 13.8 | 1.3 | 2.4 | 4.3 | 1.2 | 1.0 | 0.9 | 0.7 | 0.5 | 0.6 | 0.6 | 0.7 | |
| Total Operating Expenses | 141.4 | 141.4 | 223.9 | 254.0 | 404.7 | 272.8 | 159.5 | 111.4 | 71.8 | 46.2 | 36.4 | 30.2 | 24.9 | 18.6 | 16.2 | 14.5 | |
| Operating Income | -147.7 | -147.7 | -210.3 | -190.5 | -308.4 | -217.0 | -128.1 | -100.7 | -67.1 | -42.1 | -32.0 | -27.8 | -24.9 | -17.7 | -13.6 | -13.3 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 26.9 | 34.3 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 17.9 | 18.9 | ||
| Depreciation & Amortization | -9.8 | 3.2 | 3.3 | 3.3 | 4.8 | 4.6 | 4.7 | 4.8 | 4.9 | 4.7 | ||
| Total Operating Expenses | 23.2 | 36.5 | 38.9 | 42.9 | 63.6 | 55.5 | 47.1 | 48.2 | 44.9 | 53.2 | ||
| Operating Income | -34.7 | -34.7 | -37.0 | -41.3 | -61.7 | -52.4 | -45.1 | -51.1 | -48.1 | -51.3 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 11.1 | 11.1 | 17.3 | 17.2 | 5.8 | 1.3 | 2.4 | 4.3 | 2.2 | 0.6 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 5.8 | 0.0 | 0.0 | 1.8 | 1.7 | 1.3 | 1.6 | 2.2 | 0.5 | 0.8 | 0.5 | 0.1 | |
| Other Expense | 11.4 | 11.4 | 24.0 | 29.6 | 26.7 | 4.8 | -45.3 | 2.6 | 0.5 | -0.1 | -1.5 | -2.2 | -0.4 | -2.4 | -0.2 | 0.0 | |
| IBT | -136.3 | -136.3 | -186.3 | -160.9 | -281.7 | -212.2 | -173.4 | -98.1 | -66.6 | -43.0 | -33.5 | -30.0 | -25.9 | -20.9 | -14.2 | -13.4 | |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | -26.7 | -5.9 | -3.1 | -0.4 | 2.2 | 0.3 | -0.7 | -0.7 | 0.1 | 0.8 | 0.5 | 0.1 | |
| Net Income | -136.3 | -136.3 | -186.3 | -160.9 | -255.1 | -206.3 | -170.3 | -97.7 | -66.6 | -43.0 | -33.5 | -30.0 | -25.9 | -20.9 | -14.2 | -13.4 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 2.2 | 2.6 | 2.9 | 3.3 | 3.9 | 4.4 | 4.8 | 4.1 | 4.4 | 4.7 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 9.7 | 0.0 | ||
| Other Expense | 2.3 | 2.5 | 2.9 | 3.7 | 9.6 | 4.7 | 6.7 | 3.1 | 4.0 | 6.1 | ||
| IBT | -32.4 | -32.3 | -34.1 | -37.6 | -52.2 | -47.7 | -38.4 | -48.0 | -44.1 | -45.2 | ||
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 18.8 | -4.7 | ||
| Net Income | -32.4 | -32.3 | -34.1 | -37.6 | -52.2 | -47.7 | -38.4 | -48.0 | -44.1 | -45.2 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-1.64 | $-2.63 | $-2.18 | $-2.07 | $-1.43 | $-1.19 | $-1.02 | $-1.05 | $-1.18 | $-1.27 | $-3.54 | $-1.61 | $-1.51 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-1.64 | $-2.63 | $-2.18 | $-2.07 | $-1.43 | $-1.19 | $-1.02 | $-1.05 | $-1.18 | $-1.27 | $-3.54 | $-1.61 | $-1.51 | |
| Shares Outstanding | 118.8 | 118.8 | 113.7 | 98.4 | 96.8 | 94.7 | 82.4 | 68.2 | 56.2 | 42.0 | 31.8 | 25.5 | 20.5 | 5.9 | 8.9 | 8.9 | |
| Diluted Shares Outstanding | 118.8 | 118.8 | 113.7 | 98.4 | 96.8 | 94.7 | 82.4 | 68.2 | 56.2 | 42.0 | 31.8 | 25.5 | 20.5 | 5.9 | 8.9 | 8.9 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.45 | $-0.46 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.45 | $-0.46 | ||
| Shares Outstanding | 118.8 | 119.0 | 118.5 | 118.4 | 117.8 | 117.8 | 117.5 | 101.1 | 98.6 | 98.6 | ||
| Diluted Shares Outstanding | 118.8 | 119.0 | 118.5 | 118.4 | 117.8 | 117.8 | 117.5 | 101.1 | 98.6 | 98.6 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 36.9 | 36.1 | 41.9 | 61.3 | 133.6 | 167.3 | 99.8 | 190.5 | 89.0 | 88.6 | 64.8 | 49.1 | 54.0 | 9.1 | 6.4 | |
| Short Term Investments | 268.0 | 243.0 | 273.3 | 374.9 | 482.3 | 315.6 | 121.6 | 10.5 | 12.0 | 3.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 304.9 | 279.1 | 315.2 | 436.2 | 615.9 | 482.9 | 221.4 | 201.0 | 100.9 | 92.1 | 64.8 | 49.1 | 54.0 | 9.1 | 6.4 | |
| Accounts Receivable | 2.7 | 3.5 | 1.8 | 38.5 | 8.7 | 5.5 | 1.3 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 11.8 | 9.3 | 14.5 | 27.4 | 0.0 | 0.0 | 4.3 | 3.7 | 1.6 | 1.2 | 0.8 | 0.8 | 0.6 | 0.7 | 0.3 | |
| Total Current Assets | 319.4 | 291.9 | 331.5 | 502.1 | 633.4 | 494.3 | 227.1 | 205.2 | 102.6 | 93.3 | 65.7 | 49.9 | 54.7 | 9.8 | 6.7 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 40.6 | 41.2 | 44.9 | 36.1 | 37.9 | 36.9 | 121.3 | 41.9 | 33.3 | 46.8 | |
| Short Term Investments | 174.8 | 181.6 | 195.5 | 243.0 | 259.0 | 268.0 | 262.2 | 273.3 | 316.4 | 331.1 | |
| Total Cash & ST Investments | 215.4 | 222.8 | 240.4 | 279.1 | 296.9 | 304.9 | 383.5 | 315.2 | 349.7 | 377.9 | |
| Accounts Receivable | 0.7 | 1.4 | 2.4 | 3.5 | 4.1 | 1.0 | 0.9 | 1.8 | 1.5 | 2.8 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 5.1 | 6.2 | 5.4 | 9.3 | 9.2 | 13.5 | 10.0 | 28.2 | 12.9 | 11.4 | |
| Total Current Assets | 221.3 | 230.4 | 248.2 | 291.9 | 310.3 | 319.4 | 394.4 | 331.5 | 364.2 | 392.2 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 147.1 | 110.9 | 158.5 | 66.1 | 70.7 | 67.1 | 22.8 | 5.1 | 2.6 | 1.6 | 2.2 | 1.2 | 0.8 | 1.2 | 1.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 62.3 | 27.7 | 1.0 | 4.9 | 100.7 | 0.0 | 39.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.0 | 10.2 | 15.2 | 132.5 | 116.7 | 61.1 | 13.0 | 2.7 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Total Long-Term Assets | 209.4 | 148.8 | 174.7 | 203.5 | 288.0 | 128.1 | 75.2 | 7.8 | 2.7 | 1.7 | 2.3 | 1.3 | 0.9 | 1.3 | 1.2 | |
| Total Assets | 528.8 | 440.7 | 506.2 | 705.6 | 921.5 | 622.5 | 302.3 | 213.0 | 105.3 | 95.0 | 68.0 | 51.2 | 55.6 | 11.1 | 7.9 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 101.9 | 104.9 | 107.9 | 110.9 | 140.8 | 147.1 | 152.7 | 158.5 | 164.4 | 170.1 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 10.3 | 26.1 | 32.3 | 27.7 | 33.6 | 47.2 | 7.6 | 16.2 | 15.2 | 7.3 | |
| Other Long-Term Assets | 10.2 | 10.2 | 10.2 | 10.2 | 10.2 | 15.2 | 15.2 | 0.0 | 0.0 | 15.2 | |
| Total Long-Term Assets | 122.4 | 141.2 | 150.5 | 148.8 | 184.7 | 209.4 | 175.5 | 174.7 | 179.6 | 192.6 | |
| Total Assets | 343.7 | 371.6 | 398.7 | 440.7 | 495.0 | 528.8 | 569.9 | 506.2 | 543.8 | 584.8 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 5.5 | 9.4 | 4.7 | 8.3 | 8.6 | 6.3 | 5.8 | 4.2 | 1.7 | 0.9 | 1.0 | 0.6 | 0.7 | 2.5 | 2.1 | |
| Short-Term Debt | 6.6 | 7.4 | 12.4 | 5.6 | 5.6 | 3.4 | 1.7 | 2.4 | 7.3 | 8.2 | 7.6 | 1.5 | 1.7 | 1.9 | 1.2 | |
| Other Current Liabilities | 22.7 | 21.3 | 21.3 | 57.9 | 45.6 | 54.8 | 17.5 | 13.0 | 0.0 | 4.0 | 2.5 | 0.1 | 0.1 | 0.3 | 0.2 | |
| Current Liabilities | 34.8 | 38.5 | 39.1 | 114.1 | 81.3 | 85.6 | 27.8 | 27.3 | 11.0 | 15.2 | 13.4 | 4.6 | 4.6 | 4.9 | 3.7 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 3.5 | 4.0 | 4.2 | 9.4 | 6.3 | 5.5 | 6.8 | 4.7 | 5.7 | 7.5 | |
| Short-Term Debt | 4.8 | 5.7 | 6.5 | 7.4 | 6.9 | 6.6 | 6.4 | 12.4 | 12.0 | 11.6 | |
| Other Current Liabilities | 19.9 | 19.0 | 17.2 | 21.3 | 23.6 | 22.7 | 32.0 | 32.1 | 36.1 | 23.7 | |
| Current Liabilities | 28.1 | 28.7 | 28.2 | 38.5 | 37.4 | 34.8 | 45.4 | 39.1 | 41.3 | 44.7 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 93.9 | 77.8 | 97.4 | 103.7 | 109.2 | 93.9 | 25.2 | 12.4 | 14.8 | 2.5 | 10.7 | 18.1 | 0.0 | 1.7 | 3.6 | |
| Capital Leases | 93.9 | 85.3 | 103.5 | 109.3 | 114.8 | 97.3 | 26.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 24.2 | 11.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 131.8 | 122.0 | 137.8 | 221.6 | 242.6 | 238.0 | 57.5 | 52.6 | 28.1 | 21.9 | 29.9 | 22.9 | 4.7 | 63.9 | 58.5 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 74.5 | 75.7 | 76.8 | 77.8 | 92.1 | 93.9 | 95.7 | 97.4 | 99.0 | 100.6 | |
| Capital Leases | 79.2 | 81.3 | 83.3 | 85.3 | 99.0 | 100.6 | 102.1 | 97.4 | 105.0 | 106.3 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 109.6 | 110.3 | 110.3 | 122.0 | 132.6 | 131.8 | 143.8 | 137.8 | 141.0 | 147.0 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,298.2 | -1,398.0 | -1,211.7 | -1,050.8 | -769.1 | -556.9 | -383.5 | -285.4 | -218.8 | -175.8 | -142.4 | -112.4 | -86.5 | -65.6 | -51.4 | |
| Comprehensive Income | -0.4 | 0.3 | 0.0 | -1.9 | -0.8 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | -3.5 | -2.8 | -2.3 | -1.7 | -1.2 | |
| Total Common Equity | 397.0 | 318.7 | 368.4 | 483.9 | 678.8 | 384.4 | 244.8 | 160.5 | 77.2 | 73.2 | 38.0 | 28.3 | 50.8 | -52.8 | -50.7 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | -1,501.9 | -1,469.7 | -1,435.6 | -1,398.0 | -1,345.8 | -1,298.2 | -1,259.7 | -1,211.7 | -1,167.6 | -1,122.4 | |
| Comprehensive Income | 0.2 | 0.1 | 0.2 | 0.3 | 0.8 | -0.4 | -0.2 | 0.0 | -0.5 | -0.6 | |
| Total Common Equity | 234.1 | 261.4 | 288.4 | 318.7 | 362.3 | 397.0 | 426.1 | 368.4 | 402.8 | 437.8 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 100.6 | 85.3 | 103.5 | 109.3 | 114.8 | 97.3 | 26.9 | 14.9 | 14.8 | 10.7 | 18.2 | 19.6 | 1.7 | 3.7 | 4.8 | |
| Book Value | 397.0 | 318.7 | 368.4 | 483.9 | 678.8 | 384.4 | 244.8 | 160.5 | 77.2 | 73.2 | 38.0 | 28.3 | 50.8 | -52.8 | -50.7 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 234.1 | 261.4 | 288.4 | 318.7 | 362.3 | 397.0 | 426.1 | 368.4 | 402.8 | 437.8 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -175.7 | -136.3 | -186.3 | -160.9 | -281.7 | -212.2 | -173.4 | -98.1 | -66.6 | -43.0 | -33.5 | -30.0 | -25.9 | -20.9 | -14.2 | -13.4 | |
| Depreciation & Amortization | 19.2 | 9.3 | 19.0 | 18.3 | 13.8 | 5.9 | 3.1 | 2.2 | 1.2 | 1.0 | 0.9 | 0.7 | 0.5 | 0.6 | 0.6 | 0.7 | |
| Stock-Based Compensation | 40.2 | 24.9 | 0.0 | 43.5 | 78.7 | 54.4 | 30.8 | 17.4 | 6.3 | 3.6 | 3.2 | 2.4 | 2.4 | 1.6 | 0.2 | 0.2 | |
| Change Working Capital | -6.2 | -3.7 | -2.0 | 19.2 | -34.7 | 2.1 | -12.8 | 3.6 | 1.7 | 2.1 | 1.2 | 0.4 | 0.0 | 0.3 | 0.0 | 0.3 | |
| Change In Accounts Receivable | 1.8 | 2.6 | -1.1 | 36.7 | -29.8 | -3.2 | -5.5 | 0.5 | -0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | -8.4 | -9.0 | -1.7 | -28.9 | 14.3 | 5.9 | -1.6 | 4.3 | 4.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Inventories | -4.4 | 0.0 | 0.0 | 0.0 | 0.0 | -5.9 | 1.6 | -4.3 | -4.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 22.2 | -0.2 | 46.4 | -52.3 | -24.3 | -18.1 | 111.4 | -7.8 | 19.0 | -0.6 | -1.6 | 8.1 | 0.5 | 3.1 | 0.2 | 0.1 | |
| Cash from Operations | -140.6 | 0.0 | 0.0 | -132.3 | -248.2 | -162.9 | -39.2 | -83.2 | -38.7 | -36.9 | -29.8 | -18.4 | -22.4 | -15.4 | -13.3 | -12.1 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 0.0 | -32.3 | -34.1 | -37.6 | -52.2 | -47.7 | -38.4 | -48.0 | -44.1 | -45.2 | |
| Depreciation & Amortization | -3.8 | 3.2 | 3.3 | 3.3 | 4.8 | 4.6 | 4.7 | 4.8 | 4.9 | 4.7 | |
| Stock-Based Compensation | 0.0 | 4.9 | 7.2 | 7.4 | 9.1 | 0.0 | 9.6 | 11.0 | 9.5 | 10.1 | |
| Change Working Capital | 1.1 | 0.5 | 0.1 | -5.4 | -1.9 | 3.1 | -3.8 | 0.6 | -0.2 | -2.8 | |
| Change In Accounts Receivable | -0.2 | 0.7 | 1.0 | 1.1 | 0.6 | -2.5 | -0.2 | 1.0 | -0.3 | 1.3 | |
| Change In Accounts Payable | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 1.9 | 0.0 | 0.0 | -1.9 | -2.3 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -6.7 | 2.3 | |
| Other Non-cash Items | -20.6 | -0.7 | -1.0 | -1.5 | 12.3 | 10.5 | -4.4 | -1.8 | -12.9 | -1.9 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -36.6 | -38.3 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.9 | -6.0 | -0.7 | -6.2 | -35.6 | -50.7 | -4.9 | -7.4 | -2.3 | -1.7 | -0.5 | -1.5 | -0.9 | -0.2 | -0.7 | 0.0 | |
| Acquisitions | 47.9 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -367.1 | -195.1 | -317.8 | -358.8 | -404.8 | -968.2 | -277.3 | -248.9 | -55.7 | -40.0 | -19.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 402.1 | 311.9 | 330.7 | 477.6 | 607.1 | 694.8 | 121.2 | 98.8 | 57.5 | 31.5 | 16.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | -30.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | |
| Cash from Investing | 34.1 | 0.0 | 0.0 | 112.7 | 166.8 | -324.0 | -161.1 | -157.5 | -0.5 | -10.2 | -4.1 | -1.5 | -0.9 | -0.2 | -0.7 | 0.2 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -1.2 | -2.2 | -1.4 | -1.2 | -0.1 | -0.5 | -0.1 | -0.1 | -0.2 | -0.6 | |
| Acquisitions | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 73.3 | -25.4 | |
| Investments | -37.7 | -58.0 | -50.8 | -48.6 | -38.0 | -64.7 | -128.7 | -86.3 | -50.0 | -102.1 | |
| Sales of Investment | 66.3 | 81.4 | 71.6 | 92.5 | 60.9 | 90.7 | 75.3 | 103.7 | 95.5 | 127.5 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -73.3 | 25.4 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 45.4 | 24.8 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -15.0 | 0.0 | -10.8 | -7.7 | -1.5 | -1.8 | -3.7 | -0.3 | -0.8 | |
| Debt Issued | -5.8 | 85.3 | -18.3 | -5.8 | -5.5 | 17.5 | 70.4 | 27.0 | 0.1 | 14.9 | 0.1 | 0.2 | 19.6 | 1.7 | -0.9 | 5.6 | |
| Issuance of Common Stock | 94.6 | 0.0 | 0.0 | 0.1 | 9.2 | 411.7 | 272.7 | 162.4 | 134.6 | 43.2 | 28.8 | 36.7 | 0.1 | 40.5 | 0.2 | 0.0 | |
| Repurchase of Common Stock | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.5 | 2.7 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.5 | 0.0 | -15.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.4 | |
| Other Financing Activities | 97.4 | 0.0 | 0.0 | 0.1 | 0.0 | 41.4 | 10.1 | 2.5 | 3.5 | 15.2 | 36.6 | 0.4 | 20.0 | 23.7 | 16.7 | 7.9 | |
| Cash from Financing | 96.6 | 0.0 | 0.0 | 0.1 | 9.2 | 453.1 | 282.8 | 149.9 | 140.8 | 47.4 | 57.7 | 35.6 | 18.4 | 60.6 | 16.7 | 7.1 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 79.2 | -2.1 | -2.0 | -1.9 | -13.7 | -1.6 | -1.5 | -1.5 | -1.4 | -1.4 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -9.9 | 10.6 | -5.8 | -19.5 | -72.3 | -33.8 | 82.5 | -90.7 | 101.7 | 0.3 | 23.8 | 15.7 | -4.9 | 44.9 | 2.7 | -4.8 | |
| Closing Cash Balance | 36.9 | 56.9 | 36.1 | 57.0 | 76.6 | 148.8 | 182.6 | 100.0 | 190.7 | 89.1 | 88.6 | 64.8 | 49.1 | 54.0 | 9.1 | 6.4 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 6.0 | -0.6 | -3.7 | 8.9 | -1.9 | 1.0 | -84.4 | 79.5 | 8.5 | -13.5 | |
| Closing Cash Balance | 56.9 | 50.8 | 51.5 | 55.1 | 46.3 | 37.9 | 52.1 | 136.5 | 41.9 | 48.5 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -141.4 | -112.0 | -123.6 | -138.4 | -283.8 | -213.6 | -44.2 | -90.6 | -41.0 | -38.6 | -30.3 | -19.9 | -23.3 | -15.6 | -14.0 | -12.1 | |
| Real Free Cash Flow | -181.6 | -137.0 | -123.6 | -181.9 | -362.5 | -267.9 | -74.9 | -108.0 | -47.2 | -42.2 | -33.5 | -22.3 | -25.7 | -17.2 | -14.1 | -12.3 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -24.5 | -26.6 | -25.9 | -35.0 | -27.9 | -29.9 | -32.4 | -33.4 | -36.8 | -38.8 | |
| Real Free Cash Flow | -24.5 | -31.4 | -33.1 | -42.4 | -37.0 | -29.9 | -42.0 | -44.4 | -46.3 | -48.9 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -1 | -10.3 | -1.4 |
| P/S | 19.7 | 75.6 | 9.4 |
| P/B | 0.6 | 4.5 | 5.2 |
| P/FCF | -1 | -14.1 | -1.5 |
| Market cap | $0.1 | $2.5 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 23.1 % | 19.2 % | 0 % |
| Debt to Income | -58.1 % | -45.9 % | 0 % |
| Debt to Free cash flow | -60.3 % | -309.7 % | 0 % |
| Interest expense percentage | 0 % | -2 % | 44.7 % |
| Current ratio | 7.9 | 7 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -58.2 % | 171.3 % | 0 % |
| ROA | -39.7 % | -43.2 % | 0 % |
| CapEx to Revenue | 68.1 % | 37.4 % | 0 % |
| RaD to Revenue | 0 % | 582.3 % | 0 % |
| ROEM | 36,718.2 | 81453.9 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 100 % | 72.8 % | 68.7 % |
| Operating margin | -2448.2 % | -777.5 % | 35.5 % |
| Net margin | -2187.1 % | -761.8 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 3.9 % | 0 % |
| Dividend payout percentage | 0 % | -9.2 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 119.0 mil | 62.4 mil |
| Employee count | 0.2 tis | 0.2 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
